Structure

Physi-Chem Properties

Molecular Weight:  672.21
Volume:  639.394
LogP:  2.779
LogD:  1.691
LogS:  -3.257
# Rotatable Bonds:  12
TPSA:  227.97
# H-Bond Aceptor:  15
# H-Bond Donor:  6
# Rings:  5
# Heavy Atoms:  15

MedChem Properties

QED Drug-Likeness Score:  0.155
Synthetic Accessibility Score:  4.882
Fsp3:  0.424
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.145
MDCK Permeability:  5.356038309400901e-05
Pgp-inhibitor:  0.0
Pgp-substrate:  0.105
Human Intestinal Absorption (HIA):  0.911
20% Bioavailability (F20%):  0.909
30% Bioavailability (F30%):  0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.108
Plasma Protein Binding (PPB):  97.07369232177734%
Volume Distribution (VD):  0.401
Pgp-substrate:  6.574164390563965%

ADMET: Metabolism

CYP1A2-inhibitor:  0.055
CYP1A2-substrate:  0.058
CYP2C19-inhibitor:  0.136
CYP2C19-substrate:  0.051
CYP2C9-inhibitor:  0.422
CYP2C9-substrate:  0.12
CYP2D6-inhibitor:  0.075
CYP2D6-substrate:  0.126
CYP3A4-inhibitor:  0.37
CYP3A4-substrate:  0.153

ADMET: Excretion

Clearance (CL):  2.943
Half-life (T1/2):  0.943

ADMET: Toxicity

hERG Blockers:  0.219
Human Hepatotoxicity (H-HT):  0.127
Drug-inuced Liver Injury (DILI):  0.896
AMES Toxicity:  0.02
Rat Oral Acute Toxicity:  0.085
Maximum Recommended Daily Dose:  0.052
Skin Sensitization:  0.524
Carcinogencity:  0.772
Eye Corrosion:  0.003
Eye Irritation:  0.022
Respiratory Toxicity:  0.781

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC21956

Natural Product ID:  NPC21956
Common Name*:   6'-O-Trans-Feruloylnegundoside
IUPAC Name:   (1S,4aS,7S,7aS)-1-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-3-(4-hydroxybenzoyl)oxy-6-[[(E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxymethyl]oxan-2-yl]oxy-7-hydroxy-7-methyl-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylic acid
Synonyms:  
Standard InCHIKey:  WNQDGXDEZSWXSE-PBAPIZBRSA-N
Standard InCHI:  InChI=1S/C33H36O15/c1-33(42)12-11-19-20(29(39)40)14-45-31(25(19)33)48-32-28(47-30(41)17-5-7-18(34)8-6-17)27(38)26(37)23(46-32)15-44-24(36)10-4-16-3-9-21(35)22(13-16)43-2/h3-10,13-14,19,23,25-28,31-32,34-35,37-38,42H,11-12,15H2,1-2H3,(H,39,40)/b10-4+/t19-,23-,25-,26-,27+,28-,31+,32+,33+/m1/s1
SMILES:  C[C@@]1(CC[C@@H]2C(=CO[C@H]([C@H]12)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](COC(=O)/C=C/c2ccc(c(c2)OC)O)O1)O)O)OC(=O)c1ccc(cc1)O)C(=O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL450385
PubChem CID:   11181450
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0002049] Terpene glycosides
          • [CHEMONTID:0004081] Iridoid O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO6184 Vitex altissima Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[15620243]
NPO6184 Vitex altissima Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO6184 Vitex altissima Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT29 Organism Rattus norvegicus Rattus norvegicus Inhibition = 20.0 % PMID[495013]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC21956 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9747 High Similarity NPC109990
0.9684 High Similarity NPC145847
0.9494 High Similarity NPC179914
0.9437 High Similarity NPC476011
0.943 High Similarity NPC187205
0.9313 High Similarity NPC474936
0.9264 High Similarity NPC130730
0.9264 High Similarity NPC301910
0.9187 High Similarity NPC226759
0.9146 High Similarity NPC282551
0.908 High Similarity NPC206815
0.9062 High Similarity NPC475484
0.9051 High Similarity NPC158546
0.9051 High Similarity NPC289021
0.8988 High Similarity NPC316539
0.8957 High Similarity NPC478265
0.8957 High Similarity NPC138993
0.8931 High Similarity NPC269914
0.8931 High Similarity NPC478249
0.8929 High Similarity NPC470685
0.8896 High Similarity NPC469384
0.8889 High Similarity NPC471405
0.8882 High Similarity NPC191046
0.8882 High Similarity NPC327032
0.8882 High Similarity NPC194095
0.8875 High Similarity NPC203664
0.8864 High Similarity NPC475299
0.8862 High Similarity NPC208818
0.8855 High Similarity NPC180586
0.8834 High Similarity NPC286919
0.8834 High Similarity NPC472860
0.8834 High Similarity NPC475663
0.8834 High Similarity NPC133984
0.8827 High Similarity NPC10205
0.882 High Similarity NPC157898
0.8812 High Similarity NPC475379
0.8805 High Similarity NPC478234
0.8805 High Similarity NPC478236
0.8795 High Similarity NPC100420
0.8793 High Similarity NPC299855
0.8793 High Similarity NPC96194
0.8773 High Similarity NPC478248
0.8765 High Similarity NPC478232
0.8758 High Similarity NPC478268
0.8758 High Similarity NPC267091
0.8758 High Similarity NPC36130
0.8758 High Similarity NPC134905
0.875 High Similarity NPC117346
0.875 High Similarity NPC240592
0.875 High Similarity NPC147224
0.8743 High Similarity NPC475738
0.8743 High Similarity NPC189704
0.8742 High Similarity NPC308178
0.8735 High Similarity NPC246024
0.8728 High Similarity NPC188217
0.8727 High Similarity NPC239966
0.8727 High Similarity NPC203020
0.8713 High Similarity NPC469354
0.8712 High Similarity NPC38699
0.8712 High Similarity NPC131532
0.8704 High Similarity NPC89693
0.8704 High Similarity NPC61604
0.8704 High Similarity NPC229548
0.8704 High Similarity NPC245615
0.8704 High Similarity NPC299706
0.8704 High Similarity NPC137813
0.8704 High Similarity NPC478241
0.8704 High Similarity NPC115466
0.8698 High Similarity NPC266545
0.8698 High Similarity NPC202428
0.8696 High Similarity NPC243891
0.8693 High Similarity NPC475121
0.8693 High Similarity NPC476067
0.8688 High Similarity NPC478242
0.8688 High Similarity NPC111785
0.8688 High Similarity NPC96599
0.8679 High Similarity NPC473149
0.8678 High Similarity NPC473776
0.8678 High Similarity NPC473205
0.8667 High Similarity NPC160780
0.8667 High Similarity NPC289811
0.8663 High Similarity NPC469397
0.8663 High Similarity NPC79736
0.8663 High Similarity NPC67629
0.8659 High Similarity NPC163635
0.8659 High Similarity NPC478266
0.8642 High Similarity NPC478235
0.8642 High Similarity NPC194705
0.8639 High Similarity NPC177362
0.8639 High Similarity NPC298847
0.8639 High Similarity NPC286809
0.8634 High Similarity NPC188393
0.8634 High Similarity NPC69367
0.8634 High Similarity NPC470934
0.8623 High Similarity NPC33298
0.8623 High Similarity NPC148273
0.8623 High Similarity NPC41009
0.8623 High Similarity NPC285108
0.8613 High Similarity NPC267549
0.8608 High Similarity NPC202391
0.8608 High Similarity NPC296659
0.8606 High Similarity NPC1913
0.8605 High Similarity NPC169645
0.8605 High Similarity NPC469438
0.8605 High Similarity NPC84482
0.8596 High Similarity NPC235575
0.8589 High Similarity NPC229354
0.8589 High Similarity NPC44730
0.8588 High Similarity NPC197708
0.8588 High Similarity NPC658
0.858 High Similarity NPC200726
0.8571 High Similarity NPC35924
0.8571 High Similarity NPC199172
0.8571 High Similarity NPC476394
0.8571 High Similarity NPC100425
0.8571 High Similarity NPC98809
0.8563 High Similarity NPC25389
0.8563 High Similarity NPC108191
0.8563 High Similarity NPC93685
0.8563 High Similarity NPC311803
0.8563 High Similarity NPC472859
0.8554 High Similarity NPC76211
0.8553 High Similarity NPC34927
0.8553 High Similarity NPC34587
0.8553 High Similarity NPC476382
0.8553 High Similarity NPC100998
0.8553 High Similarity NPC252292
0.8547 High Similarity NPC195972
0.8545 High Similarity NPC11411
0.8539 High Similarity NPC71385
0.8539 High Similarity NPC230670
0.8538 High Similarity NPC43434
0.8538 High Similarity NPC472129
0.8537 High Similarity NPC469888
0.8529 High Similarity NPC229729
0.8519 High Similarity NPC158635
0.8519 High Similarity NPC205054
0.8519 High Similarity NPC229882
0.8509 High Similarity NPC472969
0.8503 High Similarity NPC166277
0.8503 High Similarity NPC289346
0.8503 High Similarity NPC119125
0.85 High Similarity NPC473867
0.8494 Intermediate Similarity NPC49173
0.8494 Intermediate Similarity NPC104275
0.8494 Intermediate Similarity NPC4747
0.8492 Intermediate Similarity NPC112708
0.8491 Intermediate Similarity NPC473281
0.8491 Intermediate Similarity NPC77922
0.8491 Intermediate Similarity NPC110063
0.8491 Intermediate Similarity NPC251062
0.8491 Intermediate Similarity NPC184464
0.8488 Intermediate Similarity NPC261254
0.8488 Intermediate Similarity NPC5786
0.8488 Intermediate Similarity NPC148185
0.8488 Intermediate Similarity NPC102851
0.8485 Intermediate Similarity NPC172920
0.8485 Intermediate Similarity NPC156624
0.8481 Intermediate Similarity NPC140502
0.848 Intermediate Similarity NPC472133
0.8466 Intermediate Similarity NPC140151
0.8462 Intermediate Similarity NPC45943
0.8462 Intermediate Similarity NPC227297
0.8457 Intermediate Similarity NPC94871
0.8457 Intermediate Similarity NPC476398
0.8457 Intermediate Similarity NPC259347
0.8457 Intermediate Similarity NPC473427
0.8457 Intermediate Similarity NPC306890
0.8457 Intermediate Similarity NPC471030
0.8457 Intermediate Similarity NPC471062
0.8457 Intermediate Similarity NPC470933
0.8457 Intermediate Similarity NPC476386
0.8448 Intermediate Similarity NPC473713
0.8448 Intermediate Similarity NPC472723
0.8447 Intermediate Similarity NPC232992
0.8444 Intermediate Similarity NPC473711
0.8443 Intermediate Similarity NPC478269
0.8443 Intermediate Similarity NPC287872
0.8443 Intermediate Similarity NPC74319
0.8443 Intermediate Similarity NPC469654
0.8439 Intermediate Similarity NPC175230
0.8439 Intermediate Similarity NPC163165
0.8439 Intermediate Similarity NPC172033
0.8439 Intermediate Similarity NPC88560
0.8439 Intermediate Similarity NPC472993
0.8438 Intermediate Similarity NPC216819
0.8438 Intermediate Similarity NPC262182
0.8438 Intermediate Similarity NPC83743
0.8438 Intermediate Similarity NPC287615
0.8434 Intermediate Similarity NPC228357
0.8434 Intermediate Similarity NPC478055
0.843 Intermediate Similarity NPC51326
0.843 Intermediate Similarity NPC212748
0.843 Intermediate Similarity NPC231194
0.8428 Intermediate Similarity NPC478250
0.8428 Intermediate Similarity NPC186296
0.8421 Intermediate Similarity NPC116745
0.8415 Intermediate Similarity NPC289438
0.8412 Intermediate Similarity NPC311830
0.8412 Intermediate Similarity NPC22832

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC21956 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9571 High Similarity NPD7685 Pre-registration
0.8563 High Similarity NPD8055 Clinical (unspecified phase)
0.8372 Intermediate Similarity NPD7054 Approved
0.8324 Intermediate Similarity NPD7074 Phase 3
0.8324 Intermediate Similarity NPD7472 Approved
0.8314 Intermediate Similarity NPD3818 Discontinued
0.8182 Intermediate Similarity NPD7808 Phase 3
0.8182 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8176 Intermediate Similarity NPD7266 Discontinued
0.8125 Intermediate Similarity NPD7251 Discontinued
0.8107 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8103 Intermediate Similarity NPD7228 Approved
0.8098 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.8068 Intermediate Similarity NPD6797 Phase 2
0.8059 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8023 Intermediate Similarity NPD7199 Phase 2
0.7952 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7907 Intermediate Similarity NPD6234 Discontinued
0.7853 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7829 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7826 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7824 Intermediate Similarity NPD1934 Approved
0.7824 Intermediate Similarity NPD37 Approved
0.7816 Intermediate Similarity NPD8127 Discontinued
0.7814 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7805 Intermediate Similarity NPD4628 Phase 3
0.7791 Intermediate Similarity NPD4966 Approved
0.7791 Intermediate Similarity NPD4965 Approved
0.7791 Intermediate Similarity NPD4967 Phase 2
0.7784 Intermediate Similarity NPD6166 Phase 2
0.7784 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7784 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7765 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7758 Intermediate Similarity NPD6190 Approved
0.7753 Intermediate Similarity NPD5844 Phase 1
0.7735 Intermediate Similarity NPD8312 Approved
0.7735 Intermediate Similarity NPD8313 Approved
0.7706 Intermediate Similarity NPD4380 Phase 2
0.7692 Intermediate Similarity NPD1653 Approved
0.7674 Intermediate Similarity NPD8455 Phase 2
0.7674 Intermediate Similarity NPD1465 Phase 2
0.7674 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.763 Intermediate Similarity NPD3817 Phase 2
0.7624 Intermediate Similarity NPD7240 Approved
0.7624 Intermediate Similarity NPD6559 Discontinued
0.7602 Intermediate Similarity NPD7028 Phase 2
0.7574 Intermediate Similarity NPD6273 Approved
0.7572 Intermediate Similarity NPD2801 Approved
0.7544 Intermediate Similarity NPD7458 Discontinued
0.7543 Intermediate Similarity NPD7075 Discontinued
0.7542 Intermediate Similarity NPD7473 Discontinued
0.7486 Intermediate Similarity NPD3882 Suspended
0.7472 Intermediate Similarity NPD6232 Discontinued
0.7471 Intermediate Similarity NPD7819 Suspended
0.7458 Intermediate Similarity NPD5494 Approved
0.7423 Intermediate Similarity NPD230 Phase 1
0.7412 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD7799 Discontinued
0.7371 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD1511 Approved
0.7333 Intermediate Similarity NPD7680 Approved
0.7333 Intermediate Similarity NPD7435 Discontinued
0.733 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7326 Intermediate Similarity NPD8434 Phase 2
0.7314 Intermediate Similarity NPD6801 Discontinued
0.7313 Intermediate Similarity NPD7930 Approved
0.7306 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7284 Intermediate Similarity NPD3027 Phase 3
0.7278 Intermediate Similarity NPD8166 Discontinued
0.7273 Intermediate Similarity NPD6653 Approved
0.7267 Intermediate Similarity NPD9494 Approved
0.7267 Intermediate Similarity NPD1512 Approved
0.7259 Intermediate Similarity NPD7999 Approved
0.7257 Intermediate Similarity NPD6386 Approved
0.7257 Intermediate Similarity NPD6385 Approved
0.7236 Intermediate Similarity NPD8151 Discontinued
0.7234 Intermediate Similarity NPD8150 Discontinued
0.7232 Intermediate Similarity NPD5402 Approved
0.7219 Intermediate Similarity NPD6674 Discontinued
0.7219 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD6355 Discontinued
0.72 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD7874 Approved
0.7186 Intermediate Similarity NPD7033 Discontinued
0.7179 Intermediate Similarity NPD6782 Approved
0.7179 Intermediate Similarity NPD6779 Approved
0.7179 Intermediate Similarity NPD6777 Approved
0.7179 Intermediate Similarity NPD6778 Approved
0.7179 Intermediate Similarity NPD6781 Approved
0.7179 Intermediate Similarity NPD6776 Approved
0.7179 Intermediate Similarity NPD6780 Approved
0.7176 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD3750 Approved
0.7176 Intermediate Similarity NPD4110 Phase 3
0.7164 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7164 Intermediate Similarity NPD7783 Phase 2
0.716 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7159 Intermediate Similarity NPD7411 Suspended
0.7157 Intermediate Similarity NPD7698 Approved
0.7157 Intermediate Similarity NPD7697 Approved
0.7157 Intermediate Similarity NPD7497 Discontinued
0.7157 Intermediate Similarity NPD7696 Phase 3
0.7152 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD3620 Phase 2
0.7143 Intermediate Similarity NPD2935 Discontinued
0.7135 Intermediate Similarity NPD5353 Approved
0.7134 Intermediate Similarity NPD3764 Approved
0.7128 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD5403 Approved
0.7125 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7121 Intermediate Similarity NPD7871 Phase 2
0.7121 Intermediate Similarity NPD8320 Phase 1
0.7121 Intermediate Similarity NPD8319 Approved
0.7121 Intermediate Similarity NPD7870 Phase 2
0.712 Intermediate Similarity NPD3751 Discontinued
0.7108 Intermediate Similarity NPD1933 Approved
0.7104 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD5762 Approved
0.7101 Intermediate Similarity NPD5763 Approved
0.71 Intermediate Similarity NPD7585 Approved
0.71 Intermediate Similarity NPD7701 Phase 2
0.7095 Intermediate Similarity NPD7768 Phase 2
0.7093 Intermediate Similarity NPD7236 Approved
0.7083 Intermediate Similarity NPD1510 Phase 2
0.7079 Intermediate Similarity NPD7801 Approved
0.7079 Intermediate Similarity NPD5761 Phase 2
0.7079 Intermediate Similarity NPD5760 Phase 2
0.7063 Intermediate Similarity NPD1608 Approved
0.7059 Intermediate Similarity NPD1549 Phase 2
0.7052 Intermediate Similarity NPD6799 Approved
0.705 Intermediate Similarity NPD7583 Approved
0.7049 Intermediate Similarity NPD5242 Approved
0.7048 Intermediate Similarity NPD1613 Approved
0.7048 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7024 Intermediate Similarity NPD7097 Phase 1
0.702 Intermediate Similarity NPD6823 Phase 2
0.7011 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7011 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7011 Intermediate Similarity NPD5401 Approved
0.7006 Intermediate Similarity NPD6599 Discontinued
0.7 Intermediate Similarity NPD6002 Phase 3
0.7 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD6005 Phase 3
0.7 Intermediate Similarity NPD6004 Phase 3
0.7 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.6995 Remote Similarity NPD3787 Discontinued
0.6994 Remote Similarity NPD6007 Clinical (unspecified phase)
0.699 Remote Similarity NPD7699 Phase 2
0.699 Remote Similarity NPD7700 Phase 2
0.6989 Remote Similarity NPD7239 Suspended
0.6977 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6977 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6968 Remote Similarity NPD6764 Approved
0.6968 Remote Similarity NPD7038 Approved
0.6968 Remote Similarity NPD6765 Approved
0.6968 Remote Similarity NPD7039 Approved
0.6965 Remote Similarity NPD7584 Approved
0.6962 Remote Similarity NPD9545 Approved
0.6961 Remote Similarity NPD3749 Approved
0.6951 Remote Similarity NPD2861 Phase 2
0.6949 Remote Similarity NPD3455 Phase 2
0.6946 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6944 Remote Similarity NPD5978 Approved
0.6944 Remote Similarity NPD5977 Approved
0.6941 Remote Similarity NPD2796 Approved
0.694 Remote Similarity NPD6959 Discontinued
0.6928 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6923 Remote Similarity NPD919 Approved
0.6923 Remote Similarity NPD6535 Approved
0.6923 Remote Similarity NPD6534 Approved
0.6914 Remote Similarity NPD2533 Approved
0.6914 Remote Similarity NPD2532 Approved
0.6914 Remote Similarity NPD2534 Approved
0.6905 Remote Similarity NPD447 Suspended
0.6898 Remote Similarity NPD8470 Clinical (unspecified phase)
0.6894 Remote Similarity NPD3705 Approved
0.689 Remote Similarity NPD5647 Approved
0.689 Remote Similarity NPD2798 Approved
0.6886 Remote Similarity NPD6663 Approved
0.6886 Remote Similarity NPD6233 Phase 2
0.6882 Remote Similarity NPD3748 Approved
0.6875 Remote Similarity NPD17 Approved
0.6872 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6871 Remote Similarity NPD1876 Approved
0.6867 Remote Similarity NPD7095 Approved
0.6857 Remote Similarity NPD8155 Clinical (unspecified phase)
0.6854 Remote Similarity NPD3226 Approved
0.6848 Remote Similarity NPD5736 Approved
0.6845 Remote Similarity NPD4140 Approved
0.6845 Remote Similarity NPD1240 Approved
0.6842 Remote Similarity NPD2438 Suspended
0.6829 Remote Similarity NPD2797 Approved
0.6826 Remote Similarity NPD3268 Approved
0.6826 Remote Similarity NPD6798 Discontinued
0.6823 Remote Similarity NPD6784 Approved
0.6823 Remote Similarity NPD6785 Approved
0.6807 Remote Similarity NPD1529 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data